The Cooper Companies, Inc. $COO Shares Sold by Figure 8 Investment Strategies LLC

Figure 8 Investment Strategies LLC lowered its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 10.3% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,633 shares of the medical device company’s stock after selling 1,558 shares during the period. Figure 8 Investment Strategies LLC’s holdings in Cooper Companies were worth $970,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of COO. Wealth Enhancement Advisory Services LLC increased its stake in Cooper Companies by 3.4% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 9,370 shares of the medical device company’s stock worth $861,000 after buying an additional 309 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Cooper Companies by 5,733.1% in the first quarter. GAMMA Investing LLC now owns 210,285 shares of the medical device company’s stock worth $17,738,000 after acquiring an additional 206,680 shares during the last quarter. Thrive Wealth Management LLC boosted its stake in shares of Cooper Companies by 11.4% in the first quarter. Thrive Wealth Management LLC now owns 3,659 shares of the medical device company’s stock worth $309,000 after acquiring an additional 373 shares during the last quarter. Impact Capital Partners LLC increased its position in shares of Cooper Companies by 4.4% during the first quarter. Impact Capital Partners LLC now owns 8,416 shares of the medical device company’s stock worth $710,000 after purchasing an additional 352 shares in the last quarter. Finally, UMB Bank n.a. raised its stake in Cooper Companies by 16.7% in the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company’s stock valued at $76,000 after purchasing an additional 129 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have issued reports on COO shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cooper Companies in a research note on Saturday, September 27th. JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $76.00 to $66.00 and set a “neutral” rating on the stock in a research note on Thursday, August 28th. UBS Group raised shares of Cooper Companies to a “buy” rating in a research note on Tuesday, June 17th. BNP Paribas upgraded shares of Cooper Companies from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 22nd. Finally, BNP Paribas Exane raised shares of Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 target price on the stock in a research note on Tuesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $84.75.

Cooper Companies Stock Up 1.9%

Shares of NASDAQ COO opened at $70.46 on Friday. The company has a market capitalization of $14.01 billion, a P/E ratio of 34.71, a P/E/G ratio of 1.81 and a beta of 1.02. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The company has a 50 day simple moving average of $69.69 and a 200-day simple moving average of $74.16. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $109.37.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.03. The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies announced that its board has authorized a stock buyback plan on Wednesday, September 17th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the medical device company to buy up to 15.4% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its shares are undervalued.

Insider Activity

In related news, COO Gerard H. Warner III acquired 1,450 shares of Cooper Companies stock in a transaction that occurred on Friday, September 5th. The shares were purchased at an average cost of $69.23 per share, for a total transaction of $100,383.50. Following the acquisition, the chief operating officer owned 18,319 shares in the company, valued at approximately $1,268,224.37. This represents a 8.60% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Daniel G. Mcbride bought 3,000 shares of the firm’s stock in a transaction on Tuesday, September 2nd. The stock was bought at an average cost of $65.04 per share, for a total transaction of $195,120.00. Following the transaction, the chief operating officer directly owned 63,120 shares of the company’s stock, valued at $4,105,324.80. The trade was a 4.99% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 17,975 shares of company stock worth $1,216,346. 1.98% of the stock is currently owned by corporate insiders.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.